DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...
Terray Therapeutics, a biotechnology company using artificial intelligence to accelerate the development of small-molecule drugs, said today it has raised $120 million in a Series B fundraise to ...
Lonza launched its AI-enabled Route Scouting Service offering which is designed to streamline synthetic route identification for novel APIs by combining Lonza’s global chemical supply chain ...
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Oligomerix, Inc., a clinical-stage biotechnology company pioneering the development of a platform of tau self-association inhibitors for Alzheimer’s disease (AD) ...
Human disease is a highly dynamic process. While next-generation genomic sequencing has provided enormous insight into the genetic underpinnings of human health and disease, dynamic measures that ...
While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development continue to face a multitude of obstacles, such as complex methodologies, high ...
Women scientists have historically been underrepresented in the field of process research and development - the space between drug discovery and manufacturing. However, over the past seven years, the ...
GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase 2 ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback